| 发明名称 |
HETEROCYCLIC SCHIFF'S BASES AS NOVEL AND NEW ANTIGLYCATION AGENTS |
| 摘要 |
The invention provides that heterocyclic Schiff bases posses protein antiglycation potential in hyperglycemia. The novel antiglycation agents 3-6 showed a moderate to potent antiglycation activity. |
| 申请公布号 |
US2014221429(A1) |
申请公布日期 |
2014.08.07 |
| 申请号 |
US201313757956 |
申请日期 |
2013.02.04 |
| 申请人 |
Al-Resayes Saud Ibrahim;Warad Ismail;Al-Nuri Mohammed A.;Choudhary Muhammad Iqbal;Wahab Atia-tul;Rasheed Saima |
发明人 |
Al-Resayes Saud Ibrahim;Warad Ismail;Al-Nuri Mohammed A.;Choudhary Muhammad Iqbal;Wahab Atia-tul;Rasheed Saima |
| 分类号 |
A61K31/444 |
主分类号 |
A61K31/444 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating advanced glycation endproduct (“AGE”)-related disorders linked to body protein glycation reaction, by administering a suitable amount of 1,3-bis(2′-pyridyl)-1,2-diazapropen-2-ene to animals and humans in need of this treatment. |
| 地址 |
Riyadh SA |
